Trademark Overview
On Wednesday, November 19, 2025, a trademark application was filed for PRIMEBODY with the United States Patent and Trademark Office. The USPTO has given the PRIMEBODY trademark a serial number of 99503974. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, July 9, 2026. This trademark is owned by Voro Therapeutics, Inc.. The PRIMEBODY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of cancer, immunerelated, autoimmune, metabolic, and inflammatory diseases; therapeutic pharmaceuticals for the treatment of cancer, immune-related, autoimmune, metabolic, and inflammatory diseases; pharmaceutical preparations, namely, a pro-drug being a drug delivery system comprising biologics in the form of masked antibodies or proteins for intravenous administration for the conditional activation release of tissue and tumor targeting pharmaceuticals; diagnostic agents, preparations, and substances for medical purposes; therapeutic agents, preparations, and substances for medical purposes, namely, masked antibodies or proteins; pharmaceutical preparations and substances for the treatment of cancer, immune-related disorders, autoimmune diseases, metabolic or cardiometabolic disorders, and inflammatory conditions in the field of oncology, immunology, autoimmune, metabolic, and inflammatory diseases; diagnostic agents and preparations in th...
Scientific and technological services, namely, research and development in the fields of pharmaceuticals, biotechnology, and medical diagnostics namely, preparations, biologics, and diagnostic agents; development of pharmaceutical drugs for oncology, immunology, autoimmune, metabolic, and inflammatory diseases, conditionally-activated and tumor-activated therapeutics and biologics; Pharmaceutical research and development services, namely, applying proprietary conditional antibody technology to the design, development, testing, and validation of pharmaceutical substances and drug candidates; conducting clinical and pre-clinical research being scientific research in the nature of conducting clinical trials for others in the field of immunotherapy, immune-modulating therapy, oncology, immunology, autoimmune, metabolic, and inflammatory diseases, pharmaceuticals and biotechnology; pharmaceutical research and development relating to the treatment of cancer, immune-related, autoimmune, metab...
